Hipragumboro-GM97 or. susp. (lyoph.) vial

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Infectious Bursal Disease Virus (live)

MAH:

Laboratorios Hipra S.A.

ATC_code:

QI01AD09

INN:

Gumboro Virus (IBDV)

pharmaceutical_form:

Lyophilisate for oral suspension

composition:

Gumboro Virus (IBDV)

administration_route:

Oral use

therapeutic_group:

poultry

therapeutic_area:

Avian Infectious Bursal Disease Virus (Gumboro Disease)

leaflet_short:

CTI code: 267005-02 - Pack size: 5000 doses - Commercialisation status: NO - CNK code: 2214930 - Delivery mode: Medical prescription; CTI code: 267005-01 - Pack size: 1000 doses - Commercialisation status: NO - CNK code: 2214922 - Delivery mode: Medical prescription; CTI code: 267005-04 - Pack size: 10 x 5000 doses - Commercialisation status: YES - CNK code: 2214930 - Delivery mode: Medical prescription; CTI code: 267005-03 - Pack size: 10 x 1000 doses - Commercialisation status: NO - CNK code: 2937357 - Delivery mode: Medical prescription

authorization_status:

Commercialised: Yes

authorization_date:

2004-09-13